ASHG News - Page 16 of 68 - ASHG

ASHG News

Jonathan Marquez, MD, PhD

Inside HGG Advances: A Chat with Jonathan Marquez

Posted By: HGG Advances HGGA: What motivated you to start working on this project? JM: From the perspective of developmental biology and physiology, I found it fascinating that a gene important for mitochondrial complex IV function could be deleted in its entirety. Yet, more important for me was the opportunity to help a family arrive... Read More

ASHG Responds to Federal Agency Layoffs

ASHG Responds to Federal Agency Layoffs

The American Society of Human Genetics (ASHG) is deeply troubled by the recent layoffs at the National Institutes of Health (NIH), the Advanced Research Projects Agency for Health (ARPA-H), National Science Foundation (NSF) and other agencies. These abrupt and unilateral decisions have far-reaching consequences that extend beyond the immediate loss of jobs. The impact on... Read More

ASHG Statement on Cuts to NIH-Funded Research Support

ASHG Statement on Cuts to NIH-Funded Research Support

The American Society of Human Genetics released the following statement in response to the recent announcement from the National Institutes of Health (NIH) regarding the implementation of a 15% reimbursement rate cap for Facilities and Administration (F&A) costs, applicable to both new and existing grants as of February 10. Although a temporary restraining order is... Read More

Jessica Honorato-Mauer, MS

Inside AJHG: A Chat with Jessica Honorato-Mauer

Posted By: Alyson Barnes, PhD, Assistant Editor, AJHG AB: What motivated you to start working on this project? JH: One of my interests in genetics research is to help reduce disparities between populations, so that we can achieve more inclusive and effective risk prediction/healthcare. Although more focused on the methodological aspects, in this project we... Read More

Inside <em>HGG Advances</em>: A Chat with Maria Gutierrez-Arcelus

Inside HGG Advances: A Chat with Maria Gutierrez-Arcelus

Posted By: HGG Advances HGGA: What motivated you to start working on this project? MG: The pathogenesis of ankylosing spondylitis (AS) remains poorly understood. In other immune-mediated diseases, integrating genome-wide association studies with epigenomics and transcriptomics has successfully identified key pathogenic cell types, such as T cells in rheumatoid arthritis and B cells in systemic... Read More